The makers of the Sputnik V vaccine suggested combining it with AstraZeneca

The vaccine from a British-Swedish pharmaceutical company is currently 62% effective.

Developers of a Russian vaccine against a new type of coronavirus Satellite V offered to combine it with the vaccine AstraZeneca to improve the effectiveness of the drug Oxford. This is indicated in a message posted on Thursday, November 26 on the page Satellite V in Twitter.

“Currently the vaccine AstraZeneca shows an efficiency of 62%. If you are conducting a new clinical trial, we suggest combining the injection AstraZeneca with Satellite V to improve efficiency “, – wrote the developers.

However, they emphasized that the combination of vaccines can be important in revaccination.

Remember in the company AstraZeneca He said his vaccine needed more research to understand the real effectiveness of the drug.

COVID vaccine may need to be retrieved – Stepanov

News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet